Further, in vitro studies showed that ACE functions to degrade Aβ, and administration of ACE inhibitors promoted the accumulation of Aβ [8-10], while in vivo studies on various mouse models of AD showed indirect evidence that ACE can degrade Aβ (reviewed in [11]). This evidence concerns the gene ACE and Alzheimer disease.